Earlier this week, LifeArc announced they are committing £10m to fund up to five collaborative projects focused on repurposing existing therapies and compounds as treatment options for bronchiectasis and cystic fibrosis. This exciting news marks the first major funding call announced as part of LifeArc’s new Chronic Respiratory Infection Translational Challenge, a £100 million programme aimed at accelerating innovative ideas into treatments for people living with cystic fibrosis bronchiectasis. The closing date is set for 15 February 2023 and more details on this funding call can be found here.
To learn more about LifeArc’s Chronic Respiratory Translational Challenge visit their website here.
